Soy extract genistein tested as potential brain saver in early Alzheimer's
NCT ID NCT07385937
First seen Feb 04, 2026 · Last updated May 01, 2026 · Updated 12 times
Summary
This study tests whether a daily supplement of genistein, a compound found in soy, can slow down memory and thinking problems in people with mild cognitive impairment (MCI) who are at risk for Alzheimer's disease. Over 18 months, 150 adults aged 50 and older will take either genistein or a placebo pill. Researchers will measure changes in cognitive function and daily living skills to see if genistein helps control the disease's progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE (AD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCAM HiTech, Sport & Health Innovation Hub
Murcia, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.